Monopar Therapeutics
MNPR
#7537
Rank
NZ$0.85 B
Marketcap
NZ$126.13
Share price
-1.84%
Change (1 day)
-22.65%
Change (1 year)

Earnings for Monopar Therapeutics (MNPR)

Earnings in 2026 (TTM): -NZ$31.04 Million

According to Monopar Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$25.08 Million, an increase over its 2024 earnings that were of -NZ$28.5 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monopar Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$31.04 Million23.78%
2025 -NZ$25.08 Million-11.99%
2024 -NZ$28.5 Million85.5%
2023 -NZ$15.36 Million-20.1%
2022 -NZ$19.23 Million15.52%
2021 -NZ$16.65 Million44.39%
2020 -NZ$11.53 Million49.23%
2019 -NZ$7.73 Million28.04%
2018 -NZ$6.04 Million-80.07%
2017 -NZ$30.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion 774.98%๐Ÿ‡บ๐Ÿ‡ธ USA